Merck Buys Again, Adding Biopharma Tilos In $773M Deal
Merck said Monday it would acquire Wilson Sonsini-led biopharmaceutical firm Tilos Therapeutics in a deal worth as much as $773 million, adding a business focused on treatments for cancer, fibrosis and...To view the full article, register now.
Already a subscriber? Click here to view full article